Related Experiment Video
Updated: Dec 31, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
985
Summary
The study clarifies the role of programmed death-1 homolog (PD-1H), a T cell cosignaling molecule. Endogenous PD-1H acts as a coinhibitory molecule, suggesting its potential as a therapeutic target in transplantation and cancer.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Two research groups independently identified a T cell cosignaling molecule, termed V-domain Ig suppressor of T cell activation (VISTA) and programmed death-1 homolog (PD-1H).
- While recombinant PD-1H functions as a coinhibitory ligand, the role of endogenous PD-1H in T cell responses remained unclear.
Purpose of the Study:
- To investigate the function of endogenous programmed death-1 homolog (PD-1H) in T cell activation.
- To provide evidence supporting PD-1H as a therapeutic target.
Main Methods:
- The study utilized experiments to demonstrate the function of endogenous PD-1H.
- Researchers examined the role of PD-1H on both T cells and antigen-presenting cells (APCs).
Main Results:
- Endogenous PD-1H on T cells and APCs functions as a coinhibitory molecule.
- This finding supports the role of PD-1H in regulating T cell activation.
Conclusions:
- Endogenous PD-1H plays a crucial role in suppressing T cell activation.
- Targeting PD-1H presents a potential therapeutic strategy for conditions such as transplantation and cancer.
Related Concept Videos
Parkinson's Disease: Overview
1.6K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Pharmacodynamics: Overview and Principles
2.7K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.7K
PD Controller: Design
558
In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
558
EPS and iPS Cells in Disease Research
3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K

